Cambridge, MA, United States of America

Tanzina Labonte

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tanzina Labonte. Retrieved from https://idiyas.com/inventor/tanzina-labonte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tanzina Labonte: Innovator in Lipid Delivery Systems

Introduction

Tanzina Labonte is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of lipid compositions and their applications in delivering therapeutically effective agents. Her innovative work has the potential to impact various medical treatments.

Latest Patents

Tanzina Labonte holds 1 patent titled "Lipids, lipid compositions, and methods of using them." This patent discloses formulation and optimization protocols for the delivery of biologically active agents to the liver, tumors, and other cells or tissues. The invention also includes compositions and uses for cationic lipid compounds and stealth lipids, along with processes for making these compounds and methods for their application.

Career Highlights

Tanzina Labonte is currently associated with Novartis AG, where she continues to advance her research in lipid delivery systems. Her work focuses on enhancing the effectiveness of drug delivery methods, which is crucial for improving patient outcomes in various therapeutic areas.

Collaborations

Tanzina collaborates with Jeremy Lee Baryza, contributing to the innovative research environment at Novartis AG. Their combined expertise fosters advancements in the field of lipid-based therapeutics.

Conclusion

Tanzina Labonte's contributions to lipid compositions and delivery methods exemplify her commitment to innovation in the medical field. Her work not only enhances drug delivery systems but also holds promise for future therapeutic advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…